{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:05:09Z","timestamp":1784174709023,"version":"3.55.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06057-7","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:15:32Z","timestamp":1784164532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tau-mediated Mechanisms in Alzheimer\u02bcs Disease Pathogenesis"],"prefix":"10.1007","volume":"63","author":[{"given":"Tanu","family":"Suma Narayanappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Ananthanarayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-2129","authenticated-orcid":false,"given":"Subashchandrabose","family":"Chinnathambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"8","key":"6057_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29(8):357\u2013365","journal-title":"Trends Immunol"},{"key":"6057_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357","journal-title":"Ageing Res Rev"},{"key":"6057_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107797","volume":"115","author":"V Tiwari","year":"2026","unstructured":"Tiwari V, Kulyal H, Tiwari A (2026) Frontiers in neurodegeneration: biomolecular triggers, diagnostic biomarkers, and smart nanotherapeutics. J Drug Deliv Sci Technol 115:107797","journal-title":"J Drug Deliv Sci Technol"},{"key":"6057_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111194","author":"G Liu","year":"2024","unstructured":"Liu G et al (2024) Cerebellum in neurodegenerative diseases: advances, challenges, and prospects. iScience. https:\/\/doi.org\/10.1016\/j.isci.2024.111194","journal-title":"iScience"},{"key":"6057_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","volume":"438","author":"H Chidambaram","year":"2020","unstructured":"Chidambaram H, Chinnathambi S (2020) G-protein coupled receptors and Tau-different roles in Alzheimer\u2019s disease. Neuroscience 438:198\u2013214","journal-title":"Neuroscience"},{"issue":"1","key":"6057_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","volume":"17","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA et al (2026) Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: pathogenesis, mechanisms, and interplay. Cell Death Dis 17(1):21","journal-title":"Cell Death Dis"},{"issue":"1","key":"6057_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-019-1412-9","volume":"16","author":"DJ Finneran","year":"2019","unstructured":"Finneran DJ, Nash KR (2019) Neuroinflammation and fractalkine signaling in Alzheimer\u2019s disease. J Neuroinflammation 16(1):30","journal-title":"J Neuroinflammation"},{"issue":"8","key":"6057_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal K et al (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7(8):656\u2013664","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"6057_CR9","doi-asserted-by":"publisher","first-page":"119477","DOI":"10.1016\/j.bbamcr.2023.119477","volume":"1870","author":"S Chinnathambi","year":"2023","unstructured":"Chinnathambi S, Das R, Desale SE (2023) Tau aggregates improve the purinergic receptor P2Y12-associated podosome rearrangements in microglial cells. Biochim Biophys Acta (BBA) Mol Cell Res 1870(5):119477","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"key":"6057_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR et al (2023) Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"6057_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s10571-022-01230-7","volume":"43","author":"I Aillaud","year":"2023","unstructured":"Aillaud I, Funke SA (2023) Tau aggregation inhibiting peptides as potential therapeutics for Alzheimer disease. Cell Mol Neurobiol 43(3):951\u2013961","journal-title":"Cell Mol Neurobiol"},{"key":"6057_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/bs.apcsb.2025.10.025","volume":"150","author":"G Velmurugan","year":"2026","unstructured":"Velmurugan G, Chandrashekar M, Chinnathambi S (2026) Actin-associated growth cone of Tau and its intracellular localization. Adv Protein Chem Struct Biol 150:119\u2013139","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"6","key":"6057_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom15060824","volume":"15","author":"X Hong","year":"2025","unstructured":"Hong X et al (2025) The role and pathogenesis of Tau protein in Alzheimer\u2019s disease. Biomolecules 15(6):824","journal-title":"Biomolecules"},{"key":"6057_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2026.103058","volume":"117","author":"W Fu","year":"2026","unstructured":"Fu W, Ho PC-L (2026) Blood-based biomarkers for Alzheimer\u2019s disease: advances in early detection and monitoring of age-related neurodegeneration. Ageing Res Rev 117:103058","journal-title":"Ageing Res Rev"},{"key":"6057_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/biom15060831","volume":"15","author":"G Jiang","year":"2025","unstructured":"Jiang G et al (2025) Cytoskeletal proteins and Alzheimer\u2019s disease pathogenesis: focusing on the interplay with Tau pathology. Biomolecules 15:831. https:\/\/doi.org\/10.3390\/biom15060831","journal-title":"Biomolecules"},{"issue":"21","key":"6057_CR16","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","volume":"15","author":"R Tenchov","year":"2024","unstructured":"Tenchov R, Sasso JM, Zhou QA (2024) Alzheimer\u2019s disease: exploring the landscape of cognitive decline. ACS Chem Neurosci 15(21):3800\u20133827","journal-title":"ACS Chem Neurosci"},{"key":"6057_CR17","volume-title":"Alzheimer\u2019s disease: etiology, neuropathology and pathogenesis","author":"OMC Sheppard","year":"2020","unstructured":"Sheppard OMC (2020) Alzheimer\u2019s disease: etiology, neuropathology and pathogenesis. Exon Publications"},{"issue":"10","key":"6057_CR18","volume":"16","author":"VS Thakor","year":"2024","unstructured":"Thakor VS et al (2024) Alois Alzheimer (1864\u20131915): the father of modern dementia research and the discovery of Alzheimer\u2019s disease. Cureus 16(10):e71731","journal-title":"Cureus"},{"issue":"5","key":"6057_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","volume":"17","author":"R Medeiros","year":"2011","unstructured":"Medeiros R, Baglietto-Vargas D, LaFerla FM (2011) The role of tau in Alzheimer\u2019s disease and related disorders. CNS Neurosci Ther 17(5):514\u2013524","journal-title":"CNS Neurosci Ther"},{"key":"6057_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213954","author":"E Passeri","year":"2022","unstructured":"Passeri E et al (2022) Alzheimer\u2019s disease: treatment strategies and their limitations. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232213954","journal-title":"Int J Mol Sci"},{"issue":"19","key":"6057_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241915023","volume":"24","author":"J Hu","year":"2023","unstructured":"Hu J et al (2023) Aggregation, transmission, and toxicity of the microtubule-associated protein Tau: a complex comprehension. Int J Mol Sci 24(19):15023","journal-title":"Int J Mol Sci"},{"key":"6057_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112970","volume":"221","author":"T Dubey","year":"2023","unstructured":"Dubey T et al (2023) The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation. Colloids Surf B Biointerfaces 221:112970","journal-title":"Colloids Surf B Biointerfaces"},{"key":"6057_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123171","volume":"234","author":"T Dubey","year":"2023","unstructured":"Dubey T et al (2023) Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells. Int J Biol Macromol 234:123171","journal-title":"Int J Biol Macromol"},{"issue":"22","key":"6057_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212335","volume":"25","author":"K Tangavelou","year":"2024","unstructured":"Tangavelou K, Bhaskar K (2024) The mechanistic link between Tau-driven proteotoxic stress and cellular senescence in Alzheimer\u2019s disease. Int J Mol Sci 25(22):12335","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6057_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12974-023-02751-8","volume":"20","author":"M Kapoor","year":"2023","unstructured":"Kapoor M, Chinnathambi S (2023) TGF-\u03b21 signalling in Alzheimer\u2019s pathology and cytoskeletal reorganization: a specialized Tau perspective. J Neuroinflammation 20(1):72","journal-title":"J Neuroinflammation"},{"key":"6057_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2018.12.005","volume":"175","author":"C Tapia-Rojas","year":"2019","unstructured":"Tapia-Rojas C et al (2019) It\u2019s all about tau. Prog Neurobiol 175:54\u201376","journal-title":"Prog Neurobiol"},{"issue":"21","key":"6057_CR27","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P et al (2022) Phosphorylated Tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23(21):12841","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6057_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40035-024-00429-6","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X et al (2024) Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies. Transl Neurodegener 13(1):40","journal-title":"Transl Neurodegener"},{"key":"6057_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","volume":"11","author":"P Barbier","year":"2019","unstructured":"Barbier P et al (2019) Role of Tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci 11:204","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"6057_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s40478-023-01702-x","volume":"11","author":"N Younas","year":"2023","unstructured":"Younas N et al (2023) Nuclear face of Tau: an inside player in neurodegeneration. Acta Neuropathol Commun 11(1):196","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"6057_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40478-017-0489-6","volume":"5","author":"I Sotiropoulos","year":"2017","unstructured":"Sotiropoulos I et al (2017) Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathol Commun 5(1):91","journal-title":"Acta Neuropathol Commun"},{"key":"6057_CR32","doi-asserted-by":"crossref","unstructured":"Michala Kolarova FGa-S, Bartos A, Ricny J, Ripova D (2012) Structure and pathology of Tau protein in Alzheimer disease. Int J Alzheimer\u02bcs Dis 2012:1\u201313","DOI":"10.1155\/2012\/731526"},{"key":"6057_CR33","doi-asserted-by":"publisher","unstructured":"Cario, A., & Berger, C. L. (2023). Tau, microtubule dynamics, and axonal transport: New paradigms for neurodegenerative disease. BioEssays : news and reviews in molecular, cellular and developmental biology, 45(8), e2200138. https:\/\/doi.org\/10.1002\/bies.202200138","DOI":"10.1002\/bies.202200138"},{"issue":"10","key":"6057_CR34","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1080\/07391102.2020.1856720","volume":"40","author":"H Chidambaram","year":"2022","unstructured":"Chidambaram H, Chinnathambi S (2022) Role of cysteines in accelerating Tau filament formation. J Biomol Struct Dyn 40(10):4366\u20134375","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"6057_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.4103\/1673-5374.385853","volume":"19","author":"D Chu","year":"2024","unstructured":"Chu D et al (2024) Tau truncation in the pathogenesis of Alzheimer\u2019s disease: a narrative review. Neural Regen Res 19(6):1221\u20131232","journal-title":"Neural Regen Res"},{"issue":"5","key":"6057_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133(5):665\u2013704","journal-title":"Acta Neuropathol"},{"issue":"9","key":"6057_CR37","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/ijms25094969","volume":"25","author":"H Zheng","year":"2024","unstructured":"Zheng H et al (2024) The enigma of tau protein aggregation: mechanistic insights and future challenges. Int J Mol Sci 25(9):4969","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6057_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-4-13","volume":"4","author":"TF Gendron","year":"2009","unstructured":"Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4(1):13","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6057_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia Y, Prokop S, Giasson BI (2021) \u201cDon\u2019t phos over tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol Neurodegener 16(1):37","journal-title":"Mol Neurodegener"},{"key":"6057_CR40","first-page":"241","volume-title":"Advances in protein chemistry and structural biology","author":"S Chinnathambi","year":"2025","unstructured":"Chinnathambi S, Velmurugan G, Chandrashekar M (2025) Chapter nine - tau protein structure and dynamics. In: Donev R (ed) Advances in protein chemistry and structural biology. Academic Press, pp 241\u2013258"},{"issue":"3","key":"6057_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1139\/bcb-2016-0227","volume":"95","author":"NL Zabik","year":"2017","unstructured":"Zabik NL, Imhof MM, Martic-Milne S (2017) Structural evaluations of tau protein conformation: methodologies and approaches. Biochem Cell Biol 95(3):338\u2013349","journal-title":"Biochem Cell Biol"},{"issue":"24","key":"6057_CR42","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1073\/pnas.1504081112","volume":"112","author":"H Kadavath","year":"2015","unstructured":"Kadavath H et al (2015) Tau stabilizes microtubules by binding at the interface between tubulin heterodimers. Proc Natl Acad Sci U S A 112(24):7501\u20137506","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6057_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13041-017-0298-7","volume":"10","author":"M Goedert","year":"2017","unstructured":"Goedert M, Spillantini MG (2017) Propagation of tau aggregates. Mol Brain 10(1):18","journal-title":"Mol Brain"},{"issue":"13","key":"6057_CR44","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","volume":"9","author":"M Goedert","year":"1990","unstructured":"Goedert M, Jakes R (1990) Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 9(13):4225\u20134230","journal-title":"EMBO J"},{"key":"6057_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-015-0025-8","volume":"10","author":"ML Caillet-Boudin","year":"2015","unstructured":"Caillet-Boudin ML et al (2015) Regulation of human MAPT gene expression. Mol Neurodegener 10:28","journal-title":"Mol Neurodegener"},{"issue":"7","key":"6057_CR46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI (2019) MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest 99(7):912\u2013928","journal-title":"Lab Invest"},{"key":"6057_CR47","doi-asserted-by":"publisher","unstructured":"Merezhko, M., Uronen, R. L., & Huttunen, H. J. (2020). The Cell Biology of Tau Secretion. Frontiers in molecular neuroscience, 13, 569818. https:\/\/doi.org\/10.3389\/fnmol.2020.569818","DOI":"10.3389\/fnmol.2020.569818"},{"issue":"1","key":"6057_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13578-020-00474-4","volume":"10","author":"H Chidambaram","year":"2020","unstructured":"Chidambaram H, Das R, Chinnathambi S (2020) Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation. Cell Biosci 10(1):109","journal-title":"Cell Biosci"},{"issue":"1","key":"6057_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s43556-021-00028-1","volume":"2","author":"SE Desale","year":"2021","unstructured":"Desale SE, Chinnathambi S (2021) \u03b1-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in microglia. Mol Biomed 2(1):4","journal-title":"Mol Biomed"},{"issue":"2","key":"6057_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bnd.2024.12.005","volume":"1","author":"H Chidambaram","year":"2025","unstructured":"Chidambaram H, Chinnathambi S (2025) LC3-associated endocytosis facilitates extracellular Tau aggregate internalization and degradation in microglia. Brain Network Disord 1(2):109\u2013121","journal-title":"Brain Network Disord"},{"issue":"1","key":"6057_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17(1):22\u201335","journal-title":"Nat Rev Neurosci"},{"issue":"19","key":"6057_CR52","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s00018-016-2216-z","volume":"73","author":"A M\u00e9phon-Gaspard","year":"2016","unstructured":"M\u00e9phon-Gaspard A et al (2016) Role of tau in the spatial organization of axonal microtubules: keeping parallel microtubules evenly distributed despite macromolecular crowding. Cell Mol Life Sci 73(19):3745\u20133760","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"6057_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12031-018-1174-3","volume":"66","author":"NV Gorantla","year":"2018","unstructured":"Gorantla NV, Chinnathambi S (2018) Tau protein squired by molecular chaperones during Alzheimer\u2019s disease. J Mol Neurosci 66(3):356\u2013368","journal-title":"J Mol Neurosci"},{"key":"6057_CR54","doi-asserted-by":"publisher","first-page":"4626540","DOI":"10.1155\/2017\/4626540","volume":"2017","author":"A Mietelska-Porowska","year":"2017","unstructured":"Mietelska-Porowska A, Wojda U (2017) T Lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer\u02bcs disease: potential pools of new biomarkers. J Immunol Res 2017:4626540","journal-title":"J Immunol Res"},{"issue":"1","key":"6057_CR55","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/s41467-023-41891-6","volume":"14","author":"M Adrian","year":"2023","unstructured":"Adrian M et al (2023) Polarized microtubule remodeling transforms the morphology of reactive microglia and drives cytokine release. Nat Commun 14(1):6322","journal-title":"Nat Commun"},{"key":"6057_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep09964","volume":"5","author":"A Elie","year":"2015","unstructured":"Elie A et al (2015) Tau co-organizes dynamic microtubule and actin networks. Sci Rep 5:9964","journal-title":"Sci Rep"},{"issue":"1","key":"6057_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner A, Ittner LM (2018) Dendritic tau in Alzheimer\u2019s disease. Neuron 99(1):13\u201327","journal-title":"Neuron"},{"issue":"1","key":"6057_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher A et al (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5(1):99","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"6057_CR59","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1523\/JNEUROSCI.4674-06.2007","volume":"27","author":"E Thies","year":"2007","unstructured":"Thies E, Mandelkow EM (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2\/Par-1. J Neurosci 27(11):2896\u20132907","journal-title":"J Neurosci"},{"issue":"3","key":"6057_CR60","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u02bcs disease mouse models. Cell 142(3):387\u2013397","journal-title":"Cell"},{"issue":"16","key":"6057_CR61","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00018-014-1610-7","volume":"71","author":"T Scholz","year":"2014","unstructured":"Scholz T, Mandelkow E (2014) Transport and diffusion of tau protein in neurons. Cell Mol Life Sci 71(16):3139\u20133150","journal-title":"Cell Mol Life Sci"},{"issue":"17","key":"6057_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179207","volume":"22","author":"J Sinsky","year":"2021","unstructured":"Sinsky J, Pichlerova K, Hanes J (2021) Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 22(17):9207","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6057_CR63","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","volume":"70","author":"M Morris","year":"2011","unstructured":"Morris M et al (2011) The many faces of tau. Neuron 70(3):410\u2013426","journal-title":"Neuron"},{"key":"6057_CR64","doi-asserted-by":"publisher","first-page":"1459573","DOI":"10.3389\/fcell.2024.1459573","volume":"12","author":"G Siano","year":"2024","unstructured":"Siano G et al (2024) Tau mediates the reshaping of the transcriptional landscape toward intermediate Alzheimer\u02bcs disease stages. Front Cell Dev Biol 12:1459573","journal-title":"Front Cell Dev Biol"},{"key":"6057_CR65","doi-asserted-by":"publisher","unstructured":"Rico, T., Gilles, M., Chauderlier, A., Comptdaer, T., Magnez, R., Chwastyniak, M., Drobecq, H., Pinet, F., Thuru, X., Bu\u00e9e, L., Galas, M. C., & Lefebvre, B. (2021). Tau Stabilizes Chromatin Compaction. Frontiers in cell and developmental biology, 9, 740550. https:\/\/doi.org\/10.3389\/fcell.2021.740550","DOI":"10.3389\/fcell.2021.740550"},{"issue":"12","key":"6057_CR66","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.4161\/cc.7.12.6012","volume":"7","author":"G Rossi","year":"2008","unstructured":"Rossi G et al (2008) A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle 7(12):1788\u20131794","journal-title":"Cell Cycle"},{"issue":"1","key":"6057_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15295","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L et al (2017) Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun 8(1):15295","journal-title":"Nat Commun"},{"issue":"1","key":"6057_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M et al (2021) The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener 10(1):45","journal-title":"Transl Neurodegener"},{"key":"6057_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/biology10101047","volume":"10","author":"T Carroll","year":"2021","unstructured":"Carroll T et al (2021) Tau post-translational modifications: potentiators of selective vulnerability in sporadic Alzheimer\u2019s disease. Biology (Basel) 10:1047. https:\/\/doi.org\/10.3390\/biology10101047","journal-title":"Biology (Basel)"},{"issue":"11","key":"6057_CR70","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.18632\/oncotarget.27963","volume":"12","author":"SK Sonawane","year":"2021","unstructured":"Sonawane SK, Chinnathambi S (2021) Epigallocatechin-3-gallate modulates Tau post-translational modifications and cytoskeletal network. Oncotarget 12(11):1083\u20131099","journal-title":"Oncotarget"},{"issue":"4","key":"6057_CR71","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12031-018-1111-5","volume":"65","author":"SK Sonawane","year":"2018","unstructured":"Sonawane SK, Chinnathambi S (2018) Prion-like propagation of post-translationally modified Tau in Alzheimer\u2019s disease: a hypothesis. J Mol Neurosci 65(4):480\u2013490","journal-title":"J Mol Neurosci"},{"key":"6057_CR72","doi-asserted-by":"publisher","unstructured":"Alquezar, C., Arya, S., & Kao, A. W. (2021). Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation. Frontiers in neurology, 11, 595532. https:\/\/doi.org\/10.3389\/fneur.2020.595532","DOI":"10.3389\/fneur.2020.595532"},{"issue":"1","key":"6057_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-021-00732-z","volume":"19","author":"AA Balmik","year":"2021","unstructured":"Balmik AA, Chinnathambi S (2021) Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer\u2019s disease. Cell Commun Signal 19(1):51","journal-title":"Cell Commun Signal"},{"issue":"12","key":"6057_CR74","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE et al (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19(12):715\u2013736","journal-title":"Nat Rev Neurol"},{"key":"6057_CR75","first-page":"467","volume-title":"Advances in protein chemistry and structural biology","author":"S Chinnathambi","year":"2024","unstructured":"Chinnathambi S, Chidambaram H (2024) Chapter fifteen - G-protein coupled receptors regulates tauopathy in neurodegeneration. In: Donev R (ed) Advances in protein chemistry and structural biology. Academic Press, pp 467\u2013493"},{"key":"6057_CR76","doi-asserted-by":"publisher","unstructured":"Sonawane, S. K., Raina, A., Majumdar, A., & Chinnathambi, S. (2020). EGCG modulates nuclear formaldehyde-induced Tau phosphorylation in Neuronal cells. bioRxiv, 2020.2010.2004.325134. https:\/\/doi.org\/10.1101\/2020.10.04.325134","DOI":"10.1101\/2020.10.04.325134"},{"issue":"8","key":"6057_CR77","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","volume":"22","author":"F Liu","year":"2005","unstructured":"Liu F et al (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22(8):1942\u20131950","journal-title":"Eur J Neurosci"},{"issue":"16","key":"6057_CR78","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1016\/j.febslet.2006.06.021","volume":"580","author":"MO Chohan","year":"2006","unstructured":"Chohan MO et al (2006) Involvement of in the abnormal hyperphosphorylation of tau and its reversal by memantine. FEBS Lett 580(16):3973\u20133979","journal-title":"FEBS Lett"},{"issue":"4","key":"6057_CR79","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","volume":"19","author":"W Qian","year":"2010","unstructured":"Qian W et al (2010) PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3\u03b2. J Alzheimers Dis 19(4):1221\u20131229","journal-title":"J Alzheimers Dis"},{"issue":"52","key":"6057_CR80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2414176121","volume":"121","author":"P Chakraborty","year":"2024","unstructured":"Chakraborty P et al (2024) GSK3\u03b2 phosphorylation catalyzes the aggregation of tau into Alzheimer\u2019s disease-like filaments. Proc Natl Acad Sci U S A 121(52):e2414176121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"6057_CR81","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","volume":"38","author":"FP Chong","year":"2018","unstructured":"Chong FP et al (2018) Tau proteins and tauopathies in Alzheimer\u2019s disease. Cell Mol Neurobiol 38(5):965\u2013980","journal-title":"Cell Mol Neurobiol"},{"issue":"19","key":"6057_CR82","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/ijms20194661","volume":"20","author":"B Mroczko","year":"2019","unstructured":"Mroczko B, Groblewska M, Litman-Zawadzka A (2019) The role of protein misfolding and tau oligomers (TauOs) in Alzheimer\u2019s disease (AD). Int J Mol Sci 20(19):4661","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6057_CR83","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack CR Jr. et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562","journal-title":"Alzheimers Dement"},{"issue":"1","key":"6057_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39328-1","volume":"14","author":"N Kyalu Ngoie Zola","year":"2023","unstructured":"Kyalu Ngoie Zola N et al (2023) Specific post-translational modifications of soluble tau protein distinguishes Alzheimer\u2019s disease and primary tauopathies. Nat Commun 14(1):3706","journal-title":"Nat Commun"},{"key":"6057_CR85","doi-asserted-by":"publisher","unstructured":"Alavi Naini, S. M., & Soussi-Yanicostas, N. (2015). Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?. Oxidative medicine and cellular longevity, 2015, 151979. https:\/\/doi.org\/10.1155\/2015\/151979","DOI":"10.1155\/2015\/151979"},{"issue":"1","key":"6057_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","volume":"12","author":"T Miyamoto","year":"2017","unstructured":"Miyamoto T et al (2017) Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture. Mol Neurodegener 12(1):41","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6057_CR87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1074\/jbc.M206236200","volume":"278","author":"JH Cho","year":"2003","unstructured":"Cho JH, Johnson GV (2003) Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J Biol Chem 278(1):187\u2013193","journal-title":"J Biol Chem"},{"issue":"3","key":"6057_CR88","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15(3):112\u2013119","journal-title":"Trends Mol Med"},{"issue":"7","key":"6057_CR89","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1007\/s12035-023-03867-x","volume":"61","author":"J Yang","year":"2024","unstructured":"Yang J et al (2024) Complicated role of post-translational modification and protease-cleaved fragments of tau in Alzheimer\u2019s disease and other tauopathies. Mol Neurobiol 61(7):4712\u20134731","journal-title":"Mol Neurobiol"},{"key":"6057_CR90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuroscience.2025.11.041","volume":"593","author":"N Baazaoui","year":"2026","unstructured":"Baazaoui N et al (2026) Targeted tau protein degradation: a promising therapeutic approach for tauopathies. Neuroscience 593:56\u201377","journal-title":"Neuroscience"},{"issue":"11","key":"6057_CR91","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z et al (2014) Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat Med 20(11):1254\u20131262","journal-title":"Nat Med"},{"issue":"3","key":"6057_CR92","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1096\/fj.08-113795","volume":"23","author":"W Noble","year":"2009","unstructured":"Noble W et al (2009) Minocycline reduces the development of abnormal tau species in models of Alzheimer\u2019s disease. FASEB J 23(3):739\u2013750","journal-title":"FASEB J"},{"issue":"1","key":"6057_CR93","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1038\/s41467-020-18405-9","volume":"11","author":"J Flores","year":"2020","unstructured":"Flores J et al (2020) Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging. Nat Commun 11(1):4571","journal-title":"Nat Commun"},{"issue":"6","key":"6057_CR94","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","volume":"67","author":"SW Min","year":"2010","unstructured":"Min SW et al (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67(6):953\u2013966","journal-title":"Neuron"},{"issue":"12","key":"6057_CR95","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/molecules29122812","volume":"29","author":"J Yang","year":"2024","unstructured":"Yang J, Zhi W, Wang L (2024) Role of Tau protein in neurodegenerative diseases and development of its targeted drugs: a literature review. Molecules 29(12):2812","journal-title":"Molecules"},{"issue":"8","key":"6057_CR96","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5483\/BMBRep.2025-0077","volume":"58","author":"YR Oh","year":"2025","unstructured":"Oh YR, Shin MK (2025) Decoding tau acetylation in Alzheimer\u2019s disease and tauopathies: from site-specific mechanisms to therapeutic horizons. BMB Rep 58(8):325\u2013339","journal-title":"BMB Rep"},{"issue":"3","key":"6057_CR97","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/aws013","volume":"135","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ et al (2012) Acetylated tau, a novel pathological signature in Alzheimer\u2019s disease and other tauopathies. Brain 135(3):807\u2013818","journal-title":"Brain"},{"key":"6057_CR98","doi-asserted-by":"crossref","unstructured":"Bryan MR Iii et al (2024) Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer\u2019s disease. Acta Neuropathol Commun 12(1):163","DOI":"10.1186\/s40478-024-01865-1"},{"issue":"11","key":"6057_CR99","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","volume":"25","author":"C Parra Bravo","year":"2024","unstructured":"Parra Bravo C, Naguib SA, Gan L (2024) Cellular and pathological functions of tau. Nat Rev Mol Cell Biol 25(11):845\u2013864","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6057_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","volume":"105","author":"MJ Lee","year":"2013","unstructured":"Lee MJ, Lee JH, Rubinsztein DC (2013) Tau degradation: the ubiquitin\u2013proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105:49\u201359","journal-title":"Prog Neurobiol"},{"issue":"10","key":"6057_CR101","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","volume":"21","author":"S-W Min","year":"2015","unstructured":"Min S-W et al (2015) Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med 21(10):1154\u20131162","journal-title":"Nat Med"},{"key":"6057_CR102","doi-asserted-by":"publisher","unstructured":"Li, L., Jiang, Y., Wang, J. Z., Liu, R., & Wang, X. (2022). Tau Ubiquitination in Alzheimer's Disease. Frontiers in neurology, 12, 786353. https:\/\/doi.org\/10.3389\/fneur.2021.786353","DOI":"10.3389\/fneur.2021.786353"},{"issue":"13","key":"6057_CR103","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1074\/jbc.RA118.006943","volume":"294","author":"CJ Huseby","year":"2019","unstructured":"Huseby CJ, Bundschuh R, Kuret J (2019) The role of annealing and fragmentation in human tau aggregation dynamics. J Biol Chem 294(13):4728\u20134737","journal-title":"J Biol Chem"},{"issue":"20","key":"6057_CR104","doi-asserted-by":"publisher","first-page":"13806","DOI":"10.1074\/jbc.M800247200","volume":"283","author":"EE Congdon","year":"2008","unstructured":"Congdon EE et al (2008) Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants. J Biol Chem 283(20):13806\u201313816","journal-title":"J Biol Chem"},{"issue":"2","key":"6057_CR105","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbadis.2004.06.016","volume":"1739","author":"J Kuret","year":"2005","unstructured":"Kuret J et al (2005) Pathways of tau fibrillization. Biochim Biophys Acta (BBA) Mol Basis Di 1739(2):167\u2013178","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Di"},{"issue":"23","key":"6057_CR106","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2174\/092986708785909111","volume":"15","author":"CX Gong","year":"2008","unstructured":"Gong CX, Iqbal K (2008) Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Curr Med Chem 15(23):2321\u20132328","journal-title":"Curr Med Chem"},{"issue":"7","key":"6057_CR107","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2(7):a006247","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"6057_CR108","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW et al (2020) Spread of pathological tau proteins through communicating neurons in human Alzheimer\u02bcs disease. Nat Commun 11(1):2612","journal-title":"Nat Commun"},{"issue":"14","key":"6057_CR109","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/j.bpj.2025.06.009","volume":"124","author":"V Das","year":"2025","unstructured":"Das V et al (2025) Intrinsic aggregation and propagation of unmodified tau peptides: R2R3 as a minimal model system. Biophys J 124(14):2339\u20132346","journal-title":"Biophys J"},{"issue":"2","key":"6057_CR110","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nchem.2889","volume":"10","author":"PM Seidler","year":"2018","unstructured":"Seidler PM et al (2018) Structure-based inhibitors of tau aggregation. Nat Chem 10(2):170\u2013176","journal-title":"Nat Chem"},{"issue":"1","key":"6057_CR111","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41398-026-03947-1","volume":"16","author":"L Bakota","year":"2026","unstructured":"Bakota L et al (2026) Beyond microtubule regulation: the multifaceted roles of tau in neuronal function and dysfunction. Transl Psychiatry 16(1):223","journal-title":"Transl Psychiatry"},{"key":"6057_CR112","doi-asserted-by":"publisher","unstructured":"Gerson, J. E., & Kayed, R. (2013). Formation and propagation of tau oligomeric seeds. Frontiers in neurology, 4, 93. https:\/\/doi.org\/10.3389\/fneur.2013.00093","DOI":"10.3389\/fneur.2013.00093"},{"issue":"9","key":"6057_CR113","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA et al (2020) Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci 77(9):1721\u20131744","journal-title":"Cell Mol Life Sci"},{"key":"6057_CR114","doi-asserted-by":"publisher","unstructured":"Sallaberry, C. A., Voss, B. J., Majewski, J., Biernat, J., Mandelkow, E., Chi, E. Y., & Vander Zanden, C. M. (2021). Tau and Membranes: Interactions That Promote Folding and Condensation. Frontiers in cell and developmental biology, 9, 725241. https:\/\/doi.org\/10.3389\/fcell.2021.725241","DOI":"10.3389\/fcell.2021.725241"},{"key":"6057_CR115","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-0716-3629-9_11","volume-title":"Tau protein: methods and protocols","author":"SE Desale","year":"2024","unstructured":"Desale SE, Chidambaram H, Chinnathambi S (2024) Biochemical and biophysical characterization of Tau and \u03b1-linolenic acid vesicles in vitro. In: Smet-Nocca C (ed) Tau protein: methods and protocols. Springer US, New York, NY, pp 193\u2013203"},{"issue":"1","key":"6057_CR116","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","volume":"76","author":"GS Gibbons","year":"2019","unstructured":"Gibbons GS, Lee VMY, Trojanowski JQ (2019) Mechanisms of cell-to-cell transmission of pathological tau: a review. JAMA Neurol 76(1):101\u2013108","journal-title":"JAMA Neurol"},{"issue":"1","key":"6057_CR117","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"DA Dionisio-Santos","year":"2019","unstructured":"Dionisio-Santos DA, Olschowka JA, O\u2019Banion MK (2019) Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. J Neuroinflammation 16(1):74","journal-title":"J Neuroinflammation"},{"issue":"3","key":"6057_CR118","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24716","volume":"80","author":"S Takeda","year":"2016","unstructured":"Takeda S et al (2016) Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer\u2019s disease mouse model and human patients. Ann Neurol 80(3):355\u2013367","journal-title":"Ann Neurol"},{"issue":"1","key":"6057_CR119","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-018-0559-4","volume":"6","author":"YS Davidson","year":"2018","unstructured":"Davidson YS et al (2018) The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer\u2019s disease in individuals with Down syndrome. Acta Neuropathol Commun 6(1):56","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"6057_CR120","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584\u20131593","journal-title":"Nat Neurosci"},{"key":"6057_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01274","volume":"13","author":"S Takeda","year":"2019","unstructured":"Takeda S (2019) Tau propagation as a diagnostic and therapeutic target for dementia: potentials and unanswered questions. Front Neurosci 13:1274","journal-title":"Front Neurosci"},{"issue":"2","key":"6057_CR122","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-013-1231-5","volume":"127","author":"F Clavaguera","year":"2014","unstructured":"Clavaguera F et al (2014) Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol 127(2):299\u2013301","journal-title":"Acta Neuropathol"},{"key":"6057_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051883","author":"Y Zhao","year":"2023","unstructured":"Zhao Y et al (2023) The potential roles of exosomes carrying APP and Tau cleavage products in Alzheimer\u2019s disease. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12051883","journal-title":"J Clin Med"},{"issue":"7","key":"6057_CR124","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11(7):909\u2013913","journal-title":"Nat Cell Biol"},{"issue":"19","key":"6057_CR125","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell*. J Biol Chem 284(19):12845\u201312852","journal-title":"J Biol Chem"},{"key":"6057_CR126","doi-asserted-by":"crossref","unstructured":"Das, R., & Chinnathambi, S. (2021). Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis. Traffic (Copenhagen, Denmark), 22(5), 153\u2013170. https:\/\/doi.org\/10.1111\/tra.12784","DOI":"10.1111\/tra.12784"},{"key":"6057_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102306","volume":"216","author":"KF Odfalk","year":"2022","unstructured":"Odfalk KF, Bieniek KF, Hopp SC (2022) Microglia: friend and foe in tauopathy. Prog Neurobiol 216:102306","journal-title":"Prog Neurobiol"},{"key":"6057_CR128","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-0716-3629-9_2","volume":"2754","author":"H Chidambaram","year":"2024","unstructured":"Chidambaram H, Desale SE, Chinnathambi S (2024) Interaction of Tau with G-protein-coupled purinergic P2Y12 receptor by molecular docking and molecular dynamic simulation. Methods Mol Biol 2754:33\u201354","journal-title":"Methods Mol Biol"},{"key":"6057_CR129","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/978-1-0716-3629-9_25","volume-title":"Tau protein: methods and protocols","author":"H Chidambaram","year":"2024","unstructured":"Chidambaram H, Desale SE, Chinnathambi S (2024) Purinergic receptor P2Y12-mediated tau internalization in microglia. In: Smet-Nocca C (ed) Tau protein: methods and protocols. Springer US, New York, NY, pp 457\u2013470"},{"key":"6057_CR130","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/bs.apcsb.2025.10.018","volume":"150","author":"S Chinnathambi","year":"2026","unstructured":"Chinnathambi S et al (2026) G-protein coupled receptor regulates cytoskeletal remodelling of extracellular Tau in Alzheimer\u2019s disease. Adv Protein Chem Struct Biol 150:245\u2013283","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"10","key":"6057_CR131","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/biom10101439","volume":"10","author":"JR Perea","year":"2020","unstructured":"Perea JR, Bol\u00f3s M, Avila J (2020) Microglia in Alzheimer\u2019s disease in the context of tau pathology. Biomolecules 10(10):1439","journal-title":"Biomolecules"},{"issue":"2","key":"6057_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14418","volume":"21","author":"KF Falkon","year":"2025","unstructured":"Falkon KF et al (2025) Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms. Alzheimers Dement 21(2):e14418","journal-title":"Alzheimers Dement"},{"key":"6057_CR133","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-0716-3902-3_11","volume-title":"Lipid signalling: methods and protocols","author":"S Chinnathambi","year":"2024","unstructured":"Chinnathambi S (2024) \u03b1-Linolenic acid vesicles-mediated tau internalization in microglia. In: Brotto M, Bhattacharya SK (eds) Lipid signalling: methods and protocols. Springer US, New York, NY, pp 117\u2013128"},{"issue":"1","key":"6057_CR134","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12974-019-1694-y","volume":"17","author":"R Das","year":"2020","unstructured":"Das R, Balmik AA, Chinnathambi S (2020) Phagocytosis of full-length Tau oligomers by actin-remodeling of activated microglia. J Neuroinflammation 17(1):10","journal-title":"J Neuroinflammation"},{"issue":"2","key":"6057_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151201","volume":"101","author":"H Chidambaram","year":"2022","unstructured":"Chidambaram H, Das R, Chinnathambi S (2022) G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau(RD)-mediated by membrane-associated actin cytoskeleton remodeling in microglia. Eur J Cell Biol 101(2):151201","journal-title":"Eur J Cell Biol"},{"key":"6057_CR136","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-0716-3662-6_16","volume-title":"Neuroprotection: method and protocols","author":"H Chidambaram","year":"2024","unstructured":"Chidambaram H et al (2024) Microglial uptake of extracellular tau by actin-mediated phagocytosis. In: Ray SK (ed) Neuroprotection: method and protocols. Springer US, New York, NY, pp 231\u2013243"},{"key":"6057_CR137","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/bs.apcsb.2024.04.001","volume":"141","author":"S Chinnathambi","year":"2024","unstructured":"Chinnathambi S, Chidambaram H (2024) G-protein coupled receptors regulates Tauopathy in neurodegeneration. Adv Protein Chem Struct Biol 141:467\u2013493","journal-title":"Adv Protein Chem Struct Biol"},{"key":"6057_CR138","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cytogfr.2025.07.003","volume":"85","author":"V Ananthanarayana","year":"2025","unstructured":"Ananthanarayana V et al (2025) Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer\u2019s disease. Cytokine Growth Factor Rev 85:118\u2013129","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"6057_CR139","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp SC et al (2018) The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J Neuroinflammation 15(1):269","journal-title":"J Neuroinflammation"},{"key":"6057_CR140","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/bs.acc.2025.06.002","volume":"128","author":"S Chinnathambi","year":"2025","unstructured":"Chinnathambi S et al (2025) Tau and amyloid beta causes microglial activation in Alzheimer\u2019s disease. Adv Clin Chem 128:83\u2013107","journal-title":"Adv Clin Chem"},{"key":"6057_CR141","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.apcsb.2024.12.002","volume":"147","author":"S Chinnathambi","year":"2025","unstructured":"Chinnathambi S et al (2025) G-protein coupled receptors (GPCRs) interacts with Tau protein in Alzheimer\u2019s disease. Adv Protein Chem Struct Biol 147:259\u2013273","journal-title":"Adv Protein Chem Struct Biol"},{"key":"6057_CR142","doi-asserted-by":"publisher","unstructured":"P\u00e9rez, M. J., Jara, C., & Quintanilla, R. A. (2018). Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration. Frontiers in neuroscience, 12, 441. https:\/\/doi.org\/10.3389\/fnins.2018.00441","DOI":"10.3389\/fnins.2018.00441"},{"key":"6057_CR143","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","volume":"1415","author":"PH Reddy","year":"2011","unstructured":"Reddy PH (2011) Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer\u2019s disease. Brain Res 1415:136\u2013148","journal-title":"Brain Res"},{"key":"6057_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111779","author":"SR Archie","year":"2021","unstructured":"Archie SR, Al Shoyaib A, Cucullo L (2021) Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13111779","journal-title":"Pharmaceutics"},{"issue":"1","key":"6057_CR145","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D et al (2023) The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther 8(1):217","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"6057_CR146","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s00018-019-03132-2","volume":"76","author":"R Das","year":"2019","unstructured":"Das R, Chinnathambi S (2019) Microglial priming of antigen presentation and adaptive stimulation in Alzheimer\u2019s disease. Cell Mol Life Sci 76(19):3681\u20133694","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"6057_CR147","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Maaser-Hecker A, Tanzi RE (2023) The neuroimmune axis of Alzheimer\u2019s disease. Genome Med 15(1):6","journal-title":"Genome Med"},{"issue":"2","key":"6057_CR148","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276","journal-title":"Nat Med"},{"key":"6057_CR149","doi-asserted-by":"crossref","unstructured":"Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023). Blood-brain barrier dysfunction and Alzheimer's disease: associations, pathogenic mechanisms, and therapeutic potential. Frontiers in aging neuroscience, 15, 1258640. https:\/\/doi.org\/10.3389\/fnagi.2023.1258640","DOI":"10.3389\/fnagi.2023.1258640"},{"issue":"1","key":"6057_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01246-y","volume":"9","author":"M Robbins","year":"2021","unstructured":"Robbins M, Clayton E, Kaminski Schierle GS (2021) Synaptic tau: a pathological or physiological phenomenon? Acta Neuropathol Commun 9(1):149","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"6057_CR151","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41593-025-01992-5","volume":"28","author":"RI McGeachan","year":"2025","unstructured":"McGeachan RI et al (2025) Evidence for trans-synaptic propagation of oligomeric tau in human progressive supranuclear palsy. Nat Neurosci 28(8):1622\u20131634","journal-title":"Nat Neurosci"},{"key":"6057_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113630","author":"M Rodr\u00edguez-Giraldo","year":"2022","unstructured":"Rodr\u00edguez-Giraldo M et al (2022) Astrocytes as a therapeutic target in Alzheimer\u2019s disease-comprehensive review and recent developments. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113630","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6057_CR153","first-page":"28","volume":"11","author":"G Niewiadomska","year":"2021","unstructured":"Niewiadomska G et al (2021) Tau oligomers neurotoxicity. Life (Basel) 11(1):28","journal-title":"Life (Basel)"},{"issue":"2","key":"6057_CR154","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14600","volume":"21","author":"L Karlsson","year":"2025","unstructured":"Karlsson L et al (2025) Machine learning prediction of tau-PET in Alzheimer\u2019s disease using plasma, MRI, and clinical data. Alzheimers Dement 21(2):e14600","journal-title":"Alzheimers Dement"},{"issue":"7","key":"6057_CR155","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11910-019-0962-7","volume":"19","author":"YT Wang","year":"2019","unstructured":"Wang YT, Edison P (2019) Tau imaging in neurodegenerative diseases using positron emission tomography. Curr Neurol Neurosci Rep 19(7):45","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"6057_CR156","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2967\/jnumed.120.252254","volume":"61","author":"VS Mattay","year":"2020","unstructured":"Mattay VS et al (2020) Brain Tau imaging: food and drug administration approval of 18F-flortaucipir injection. J Nucl Med 61(10):1411","journal-title":"J Nucl Med"},{"key":"6057_CR157","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268756","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD et al (2025) Updated appropriate use criteria for amyloid and Tau PET: a report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging workgroup. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.124.268756","journal-title":"J Nucl Med"},{"issue":"2","key":"6057_CR158","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","volume":"35","author":"G Cassinelli Petersen","year":"2022","unstructured":"Cassinelli Petersen G et al (2022) Overview of tau PET molecular imaging. Curr Opin Neurol 35(2):230\u2013239","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"6057_CR159","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-023-02672-z","volume":"147","author":"C Aguero","year":"2024","unstructured":"Aguero C et al (2024) Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases. Acta Neuropathol 147(1):25","journal-title":"Acta Neuropathol"},{"key":"6057_CR160","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","volume":"97","author":"M Sch\u00f6ll","year":"2019","unstructured":"Sch\u00f6ll M et al (2019) Biomarkers for tau pathology. Mol Cell Neurosci 97:18\u201333","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"6057_CR161","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF et al (2013) [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement 9(6):666\u2013676","journal-title":"Alzheimers Dement"},{"issue":"4","key":"6057_CR162","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00401-017-1740-8","volume":"134","author":"M Marqui\u00e9","year":"2017","unstructured":"Marqui\u00e9 M et al (2017) [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging. Acta Neuropathol 134(4):619\u2013628","journal-title":"Acta Neuropathol"},{"issue":"2","key":"6057_CR163","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-122059","volume":"34","author":"DT Chien","year":"2013","unstructured":"Chien DT et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34(2):457\u2013468","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"6057_CR164","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/brain\/awab120","volume":"144","author":"SY Yap","year":"2021","unstructured":"Yap SY et al (2021) Discriminatory ability of next-generation tau PET tracers for Alzheimer\u2019s disease. Brain 144(8):2284\u20132290","journal-title":"Brain"},{"issue":"1","key":"6057_CR165","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00401-025-02864-9","volume":"149","author":"S Ghatamaneni","year":"2025","unstructured":"Ghatamaneni S et al (2025) High resolution autoradiography of [(18)F]MK-6240 and [(18)F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturity. Acta Neuropathol 149(1):26","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6057_CR166","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13195-024-01622-5","volume":"16","author":"M Tonietto","year":"2024","unstructured":"Tonietto M et al (2024) Head-to-head comparison of tau PET tracers [(18)F]PI-2620 and [(18)F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort. Alzheimers Res Ther 16(1):257","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"6057_CR167","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13195-025-01868-7","volume":"17","author":"M Malpetti","year":"2025","unstructured":"Malpetti M et al (2025) Regional tau PET patterns predict prospective domain-specific cognitive decline in early symptomatic Alzheimer\u2019s disease. Alzheimers Res Ther 17(1):220","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"6057_CR168","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-019-02087-9","volume":"139","author":"M Colin","year":"2020","unstructured":"Colin M et al (2020) From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy. Acta Neuropathol 139(1):3\u201325","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6057_CR169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13195-023-01173-1","volume":"15","author":"R Mohanty","year":"2023","unstructured":"Mohanty R et al (2023) Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer\u2019s disease continuum: biological and methodological perspectives from disease heterogeneity. Alzheimers Res Ther 15(1):37","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"6057_CR170","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1136\/jnnp-2021-328623","volume":"93","author":"J Lagarde","year":"2022","unstructured":"Lagarde J et al (2022) Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 93(5):459","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"6057_CR171","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","volume":"78","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R et al (2021) Accuracy of Tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol 78(8):961\u2013971","journal-title":"JAMA Neurol"},{"key":"6057_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics10010027","author":"A Gogola","year":"2025","unstructured":"Gogola A et al (2025) Tau imaging: use and implementation in new diagnostic and therapeutic paradigms for Alzheimer\u02bcs disease. Geriatrics (Basel). https:\/\/doi.org\/10.3390\/geriatrics10010027","journal-title":"Geriatrics (Basel)"},{"issue":"18","key":"6057_CR173","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","volume":"111","author":"H Hampel","year":"2023","unstructured":"Hampel H et al (2023) Blood-based biomarkers for Alzheimer\u2019s disease: current state and future use in a transformed global healthcare landscape. Neuron 111(18):2781\u20132799","journal-title":"Neuron"},{"key":"6057_CR174","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/606802","author":"A Anoop","year":"2010","unstructured":"Anoop A et al (2010) CSF biomarkers for Alzheimer\u2019s disease diagnosis. Int J Alzheimers Dis. https:\/\/doi.org\/10.4061\/2010\/606802","journal-title":"Int J Alzheimers Dis"},{"issue":"4","key":"6057_CR175","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s13311-023-01370-8","volume":"20","author":"WT Hu","year":"2023","unstructured":"Hu WT, Nayyar A, Kaluzova M (2023) Charting the next road map for CSF biomarkers in Alzheimer\u2019s disease and related dementias. Neurotherapeutics 20(4):955\u2013974","journal-title":"Neurotherapeutics"},{"issue":"1","key":"6057_CR176","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1038\/s41467-025-63545-5","volume":"16","author":"C Soares","year":"2025","unstructured":"Soares C et al (2025) CSF total tau as a proxy of synaptic degeneration. Nat Commun 16(1):8076","journal-title":"Nat Commun"},{"issue":"1","key":"6057_CR177","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","volume":"147","author":"J Lantero-Rodriguez","year":"2024","unstructured":"Lantero-Rodriguez J et al (2024) CSF p-tau205: a biomarker of tau pathology in Alzheimer\u2019s disease. Acta Neuropathol 147(1):12","journal-title":"Acta Neuropathol"},{"issue":"3","key":"6057_CR178","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s43440-020-00107-0","volume":"72","author":"P Lewczuk","year":"2020","unstructured":"Lewczuk P et al (2020) Clinical significance of fluid biomarkers in Alzheimer\u2019s disease. Pharmacol Rep 72(3):528\u2013542","journal-title":"Pharmacol Rep"},{"key":"6057_CR179","doi-asserted-by":"crossref","unstructured":"Hirota Y et al (2022) Distinct brain pathologies associated with Alzheimer\u02bcs disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-\u03b2 amyloidosis. Brain Commun 4(6):fcac286","DOI":"10.1093\/braincomms\/fcac286"},{"issue":"1","key":"6057_CR180","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40478-021-01307-2","volume":"10","author":"M Wennstr\u00f6m","year":"2022","unstructured":"Wennstr\u00f6m M et al (2022) Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels. Acta Neuropathol Commun 10(1):3","journal-title":"Acta Neuropathol Commun"},{"issue":"13","key":"6057_CR181","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.3390\/ijms23137307","volume":"23","author":"S Holper","year":"2022","unstructured":"Holper S, Watson R, Yassi N (2022) Tau as a biomarker of neurodegeneration. Int J Mol Sci 23(13):7307","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6057_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076523","volume":"8","author":"JE Meredith Jr","year":"2013","unstructured":"Meredith JE Jr et al (2013) Characterization of novel CSF Tau and ptau biomarkers for Alzheimer\u2019s disease. PLoS ONE 8(10):e76523","journal-title":"PLoS ONE"},{"issue":"8","key":"6057_CR183","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awab481","volume":"145","author":"A Snellman","year":"2022","unstructured":"Snellman A et al (2022) N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases. Brain 145(8):2834\u20132848","journal-title":"Brain"},{"issue":"1","key":"6057_CR184","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-024-00707-x","volume":"19","author":"J Lantero-Rodriguez","year":"2024","unstructured":"Lantero-Rodriguez J et al (2024) Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer\u2019s Disease. Mol Neurodegener 19(1):19","journal-title":"Mol Neurodegener"},{"issue":"7","key":"6057_CR185","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jnnp-2018-319266","volume":"90","author":"MS Foiani","year":"2019","unstructured":"Foiani MS et al (2019) Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest. J Neurol Neurosurg Psychiatry 90(7):740","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6057_CR186","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-018-1948-2","volume":"137","author":"C Cicognola","year":"2019","unstructured":"Cicognola C et al (2019) Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer\u2019s disease. Acta Neuropathol 137(2):279\u2013296","journal-title":"Acta Neuropathol"},{"key":"6057_CR187","doi-asserted-by":"publisher","unstructured":"Wang, L., Sooram, B., Kumar, R., Schedin-Weiss, S., Tjernberg, L. O., & Winblad, B. (2025). Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(3), e70048. https:\/\/doi.org\/10.1002\/alz.70048","DOI":"10.1002\/alz.70048"},{"key":"6057_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081836","volume":"12","author":"R Lai","year":"2024","unstructured":"Lai R, Li B, Bishnoi R (2024) P-tau217 as a reliable blood-based marker of Alzheimer\u2019s disease. Biomedicines 12:1836. https:\/\/doi.org\/10.3390\/biomedicines12081836","journal-title":"Biomedicines"},{"issue":"9","key":"6057_CR189","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH et al (2021) Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol 20(9):739\u2013752","journal-title":"Lancet Neurol"},{"key":"6057_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110330","volume":"26","author":"KY Kim","year":"2025","unstructured":"Kim KY, Shin KY, Chang K-A (2025) Blood-based tau as a biomarker for early detection and monitoring of Alzheimer\u2019s disease: a systematic review and meta-analysis. Int J Mol Sci 26:10330. https:\/\/doi.org\/10.3390\/ijms262110330","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6057_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2026.100502","volume":"13","author":"K Kasuga","year":"2026","unstructured":"Kasuga K et al (2026) Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: observations from Japanese Alzheimer\u2019s disease neuroimaging initiative cohort. J Prev Alzheimers Dis 13(4):100502","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"6057_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103658","volume":"25","author":"JD Manos","year":"2022","unstructured":"Manos JD et al (2022) Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model. iScience 25(1):103658","journal-title":"iScience"},{"issue":"6","key":"6057_CR193","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","volume":"17","author":"J Mertens","year":"2015","unstructured":"Mertens J et al (2015) Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17(6):705\u2013718","journal-title":"Cell Stem Cell"},{"issue":"1","key":"6057_CR194","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work. Brain Res Rev 33(1):95\u2013130","journal-title":"Brain Res Rev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06057-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:56:07Z","timestamp":1784174167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06057-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":194,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6057"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06057-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"769"}}